🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ESDO Bullets Video 🎞️ Learn about GI Oncology papers from 01/2024 in 1 minute! #my_UEG #Cancer

The addition of pembrolizumab or atezolizumab to periop CTx improves the pCR rate, but pembrolizumab fails to improve EFS in gastric or gastro-esophageal adenocarcinoma (KEYNOTE-585 & DANTE). 🗝️ Check out our summary of 02/2024 in GI Oncology.

The alternating nab-P/Gem - mFOLFOX regimen improves 12-mo OS as compared to the standard nab-P/Gem in 1L treatment of metastatic pancreatic cancer (55% vs 35%). 🔁 Check out our Bulletin for more:

Check out our Bulletin covering GI Oncology papers from 03/2024! 📢 my_UEG esdo.eu/publications-r…

Don't miss our Bulletin spotlighting GI Oncology papers from April 2024! 🚨 my_UEG esdo.eu/publications-r…

Stay up-to-date with GI cancer updates from ASCO 2024! See our Bulletin covering mCRC (02 June) 🎗️ #GICancer #CancerResearch #ASCO24

ESDO Bulletin: Stay up-to-date with news in GI cancer from #ASCO24! ESOPEC: FLOT trumps CROSS in esophageal cancer!

Catch the latest updates on gastroesophageal cancer from #ASCO24 in ESDO Bullets! my_UEG

see you ESMO - Eur. Oncology GI Cancers Congress in Munich

🔬 Stay updated on GI oncology! Check out the ESDO Bullets: May 2024 pubs! esdo.eu/publications-r… my_UEG

Stay updated on GI oncology! 🔖 Check out the ESDO Bullets: June 2024 pubs! esdo.eu/publications-r…… my_UEG

hurry to register for 8th ESDO Masterclass *Novel Strategies in GI Oncology* at Arcotel John F. Berlin on 8/9 November 2024 esdo.eu/education/esdo… #DGVSJuGa #myueg #cancer #oncology #dice_europe #P_C_E_

🟢🟢Delight to launch with Livia Archibugi the new my_UEG project on “Quality indicators in pancreatic ductal adenocarcinoma” From Vienna 🇦🇹 we demand better care for our patients !!!

🔪Salvage surgery for unifocal progressive metastatic dMMR GI cancer responding to #ICI ascopubs.org/doi/10.1200/PO… Interesting new article in JCO Precision Oncology from our UZ Leuven / KU Leuven team. 💪 Jeroen Dekervel, Filip Van Herpe, Baki Topal, Christophe Deroose, Decaestecker Jochen, Albert Wolthuis et al.

we invite @YOU_Oncology residents & #oncology fellows to 8th ESDO Masterclass *Novel Strategies in GI Oncology* - enjoy an outstanding interactive program tinyurl.com/program1124 with a great faculty including Michael Quante Sebastian Stintzing Christoph Stein-Thoeringer, MD Mathias Heikenwälder Arndt Vogel

Today is a good day! Our new paper on a Belgian cohort of 283 high grade neuroendocrine neoplasms receives Thor Halfdanarson's stamp of approval. More on NET G3 vs NEC, functional imaging,... through erc.bioscientifica.com/view/journals/… NETwerk Willem Lybaert

listen to the NEW ESDO PODCAST! Dr. Violaine RANDRIAN, gastroenterologist at CHU Poitiers, France discusses the characteristics and management of Appendix Cancer with Dr. Michael Foote, GI oncologist at MSKCC, New York, USA esdo.eu/fileadmin/user…

Turning ambitious ideas 💡 into reality with Livia Archibugi my_UEG and EPC-Europ Pancr Club !!! 🟢 The quality indicators in pancreas cancer project is now up and running.. to elevate the level of care in Europe and beyond! Thank you to all the amazing experts for participating! 🚀

📢 Stay up-to-date with the latest in GI oncology! 📰 Check out the ESDO Bullets covering April 2025

🎥 #ESMOGI2025 Highlight! Dr Pieter-Jan Cuyle discusses key advances in mCRC: ✔️ ctDNA surveillance increases curative-intent treatments (FIND, GALAXY, BESPOKE) ✔️ ctDNA-based anti-EGFR re-challenge improves ORR/DCR (PARERE trial) ✔️ Topical BRAF inhibitor reduces EGFR-related skin rash